Predicción y previsión de precio de Strata Critical Medical Inc (SRTA)SRTAStrata Critical Medical Inc

Alphio's SRTA stock price prediction model matches the current Strata Critical Medical Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $5.44 (+1.26%). The 1-week path is $5.18 (-3.51%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Strata Critical Medical Inc (SRTA) is a good buy right now due to its recent strong performance and positive outlook. The current price is $5.97, significantly lower than the analyst price targets of $8 and $11.50, indicating a potential upside of 33.5% to 93.5%. The company reported a 15.1% sequential increase in clinical revenue for Q2 2026, reaching $24.3 million, and raised its revenue guidance for 2026 to between $285 million and $295 million. However, the main risk is the negative net income reported for Q2 2026, amounting to -$10.52 million, which could affect investor sentiment.

Strata Critical Medical Inc (SRTA) last closed at $5.37, losing -0.37%. These facts feed the 1-day and 1-week SRTA price prediction above.